News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Prenatal Dx Startup KellBenx, Inc. Eyes $10 Million in Funding Round


7/24/2013 8:43:51 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A New York startup is aiming to provide an alternative to the traditional prenatal blood tests by developing a DNA test that analyzes fetal cells that are intact within a maternal blood sample. The company - KellBenx - is seeking $10 million, according to a regulatory filing. Previously, it appears to have raised $2.5 million in the second quarter of 2011. Aside from developing a non-invasive, DNA-based diagnostic test to detect genetic abnormalities in fetuses, KellBenx is also aiming to develop a breakthrough test to determine a pregnant woman's chances of delivery prematurely.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES